Press Releases

Year

Feb 01 2024

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 1, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S , today announced it will release its fourth quarter and full year 2023 financial results before U.S.

PDF Version

Jan 22 2024

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 22, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities. The Company is seeking to refinance its first lien

PDF Version

Jan 11 2024

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

New report reveals that by improving medication access and adherence, GoodRx has helped save Americans $65 billion and the healthcare system over $5 billion SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 11, 2024-- GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared

PDF Version

Jan 10 2024

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

Preliminary fourth quarter Revenue and Adjusted Revenue exceed previously announced guidance SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 10, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary

PDF Version

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Displaying 31 - 34 of 34

Press Releases

site - Investor Tools